Search Images - Patrick McMullan
Alexis Borisy, Partner of Third Rock Ventures LLC., attends the EmTech China at the China World Hotel in Beijing, China, 29 January 2018. The EmTech Stock Photo - Alamy
Alexis Borisy - Executive Chairman, Board of Directors at EQRx | The Org
Alexis Borisy - Donate Your Data - YouTube
Cambridge biotech EQRx raises $500m to try to make drugs more cheaply - The Boston Globe
Profile: Alexis Borisy | Nature Biotechnology
New Cambridge-based, Third Rock-backed biotech revealed in federal filing - Boston Business Journal
Alexis Borisy - HIT Pre-reception and Annual Breakfast, 11/16/14 | Combined Jewish Philanthropies of Greater Boston
Third Rock closes $616M life sciences fund, takes on ex-Eleven Bio CEO | Fierce Biotech
EQRx sells to another Alexis Borisy biotech after multiple pivots - Boston Business Journal
Alexis Borisy - Curie.Bio | LinkedIn
Alexis Borisy | MIT Technology Review
First Rounders: Alexis Borisy | Research Communities by Springer Nature
Alexis Borisy, Founder, Chief Executive Officer, Executive Chairman - eMedEvents
Alexis Borisy, Partner at Third Rock Ventures | Harvard Stem Cell Institute (HSCI)
Alexis Borisy - Director at REVOLUTION Medicines | The Org
New Drugs at Low Prices: Alexis Borisy and Melanie Nallicheri of EQRx on The Long Run - TimmermanReport.com
Alexis Borisy on Vimeo
Alexis Borisy | Board Member | Tango Therapeutics, Inc
Alexis Borisy – Relay Therapeutics
Alexis Borisy, Partner of Third Rock Ventures LLC., attends the EmTech China at the China World Hotel in Beijing, China, 29 January 2018. The EmTech Stock Photo - Alamy
JPM: JetBlue, but for biopharma: Borisy's EQRx nabs $200M, takes aim at drug prices | Fierce Biotech
